Loading clinical trials...
Loading clinical trials...
DHA, Inflammation, and Insulin Sensitivity
Conditions
Interventions
DHA Supplements
Placebo Supplements
Locations
1
United States
General Clinical Research Center
Cincinnati, Ohio, United States
Start Date
April 1, 2009
Primary Completion Date
July 1, 2011
Completion Date
July 1, 2011
Last Updated
July 15, 2009
NCT00001987
NCT07483723
NCT07460856
NCT06277232
NCT07395973
NCT07297290
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions